Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

NCT01849146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

NIH

Sponsor class

Conditions

Glioblastoma
Recurrent Glioblastoma

Interventions

DRUG: Adavosertib
RADIATION: Radiation Therapy
DRUG: Temozolomide

Sponsor

National Cancer Institute (NCI)